Literature DB >> 11716514

Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors.

E J Wang1, C N Casciano, R P Clement, W W Johnson.   

Abstract

With P-glycoprotein (P-gp) continuing to have prominence among the ABC transporters for its ability to remove various xenobiotics from many cell types, accurate and robust methods for estimating the exposure of drug, carcinogen, toxicant, pesticide, and even some endobiotics to tissues and cells affected by P-gp are valuable. The inhibition of P-gp active transport of molecules, therefore, has often been quantified by concentration dependence of inhibitor effect on fluorescent substrate marker efflux mediated by this enzyme, with much evidence indicating two asymmetric yet interdependent substrate binding sites on P-gp. A uniqueness in the pair of binding sites could result in distinct effects of an inhibitor on the transport of certain substrates, thus leading to differences in fluorescent substrate responsiveness or sensitivity. Seven different fluorescent substrates of P-gp were quantitatively tested for their responsiveness to inhibition by a wide range of P-gp substrates/inhibitors. Interesting differences were observed in the IC(50) values caused by each of the inhibitors employed, in part exemplified by DNR and LDS being generally more sensitive to inhibition effects than any other fluorescent marker. However, no clear trend emerged to designate any fluorochrome marker as the most or least responsive to inhibition. Furthermore, LDS is more sensitive to some P-gp inhibitors than the substrate marker DNR, generally the most responsive. These results support the assertion of two unequal substrate binding sites that are allosterically dependent on each other. Therefore, an inhibitor that favors binding to the site opposite from that favored by a particular marker may have significant transduced effects through the protein between the two binding sites. Nevertheless, although either DNR or LDS is generally the fluorescent substrate most responsive to inhibition, there may be other substrates yet even more sensitive.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11716514     DOI: 10.1006/bbrc.2001.6000

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

1.  Inhibition of efflux transporter-mediated fungicide resistance in Pyrenophora tritici-repentis by a derivative of 4'-hydroxyflavone and enhancement of fungicide activity.

Authors:  Sven Reimann; Holger B Deising
Journal:  Appl Environ Microbiol       Date:  2005-06       Impact factor: 4.792

Review 2.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

3.  Increased affinity to canalicular P-gp via formation of lipophilic ion-pair complexes with endogenous bile salts is associated with mw threshold in hepatobiliary excretion of quaternary ammonium compounds.

Authors:  Im-Sook Song; Min-Koo Choi; Qing-Ri Jin; Won-Sik Shim; Chang-Koo Shim
Journal:  Pharm Res       Date:  2010-03-10       Impact factor: 4.200

4.  Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites.

Authors:  Er-jia Wang; Christopher N Casciano; Robert P Clement; William W Johnson
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

5.  ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cells.

Authors:  Aurélie Thollet; Julie A Vendrell; Léa Payen; Sandra E Ghayad; Sabrina Ben Larbi; Evelyne Grisard; Colin Collins; Marie Villedieu; Pascale A Cohen
Journal:  Mol Cancer       Date:  2010-11-08       Impact factor: 27.401

6.  Inhibitory effect of a bitter melon extract on the P-glycoprotein activity in intestinal Caco-2 cells.

Authors:  Tomoko Konishi; Hideo Satsu; Yasuo Hatsugai; Koichi Aizawa; Takahiro Inakuma; Shinji Nagata; Sho-Hei Sakuda; Hiromichi Nagasawa; Makoto Shimizu
Journal:  Br J Pharmacol       Date:  2004-09-06       Impact factor: 8.739

Review 7.  Advancement of structure-activity relationship of multidrug resistance-associated protein 2 interactions.

Authors:  Li Xing; Yiding Hu; Yurong Lai
Journal:  AAPS J       Date:  2009-06-03       Impact factor: 4.009

8.  Fluorescent substrates for flow cytometric evaluation of efflux inhibition in ABCB1, ABCC1, and ABCG2 transporters.

Authors:  J Jacob Strouse; Irena Ivnitski-Steele; Anna Waller; Susan M Young; Dominique Perez; Annette M Evangelisti; Oleg Ursu; Cristian G Bologa; Mark B Carter; Virginia M Salas; George Tegos; Richard S Larson; Tudor I Oprea; Bruce S Edwards; Larry A Sklar
Journal:  Anal Biochem       Date:  2013-03-05       Impact factor: 3.365

9.  Cooperation between prokaryotic (Lde) and eukaryotic (MRP) efflux transporters in J774 macrophages infected with Listeria monocytogenes: studies with ciprofloxacin and moxifloxacin.

Authors:  Ann Lismond; Paul M Tulkens; Marie-Paule Mingeot-Leclercq; Patrice Courvalin; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2008-06-23       Impact factor: 5.191

Review 10.  Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators.

Authors:  Ahmad R Safa
Journal:  Curr Med Chem Anticancer Agents       Date:  2004-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.